Richard Bartram Esperion Therapeutics, Inc. (ESPR) insider trading activity

ESPR Quotes by TradingView

Richard Bartram is Chief Financial Officer of Esperion Therapeutics, Inc.. Currently has a direct ownership of 82,751 shares of ESPR, which is worth approximately $188,672. The most recent transaction as insider was on Mar 14, 2022, when has been sold 37,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 82.8K
0% 3M change
0% 12M change
Total Value Held $188,672

Richard Bartram Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 14 2022
BUY
Grant, award, or other acquisition
-
37,000 Added 30.9%
82,751 Common Stock
Oct 29 2021
BUY
Grant, award, or other acquisition
-
18,700 Added 29.9%
43,852 Common Stock
Jan 28 2021
BUY
Grant, award, or other acquisition
-
5,000 Added 17.47%
23,617 Common Stock

Also insider at

MBX
MBX Biosciences, Inc.
Chief Financial Officer
RB

Richard Bartram

Chief Financial Officer
Ann Arbor, MI

Track Institutional and Insider Activities on ESPR

Follow Esperion Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ESPR shares.

Notify only if

Insider Trading

Get notified when an Esperion Therapeutics, Inc. insider buys or sells ESPR shares.

Notify only if

News

Receive news related to Esperion Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ESPR